EP2400950
Lyfjasamsetningar sem innihalda 4-{(1R)-2-[(6-{2-[(2,6-díklórbensýl)oxý]etoxý}hexýl)amínó]-1-hýdroxýetýl}-2-(hýdroxýmetýl)fenól
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
26.2.2009EP published:
22.5.2019EP application number:
09779096.8
EP translation filed:
31.7.2019Grant published:
15.10.2019EPO information:
European Patent Register
Max expiry date:
25.2.2029Expiry date:
25.2.2027
Title:
PHARMACEUTICAL FORMULATIONS COMPRISING 4-{(1 R)-2-[(6-{2-[(2,6-DICHLOROBENZYL)OXY]ETHOXY}HEXYL)AMINO]-1-HYDROXYETHYL}-2-(HYDROXYMETHYL)PHENOL
Timeline
Today
26.2.2009EP application
22.5.2019EP Publication
31.7.2019Translation submitted
15.10.2019Registration published
25.2.2027Expires
Owner
Name:
Glaxo Group LimitedAddress:
GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, GB
Inventor
Name:
BAKER, DarrellAddress:
UxbridgeMiddlesex UB11 1BT, GB
Name:
BRUCE, MarkAddress:
StevenageHertfordshire SG1 2NY, GB
Name:
THOMAS, MarianAddress:
WareHertfordshire SG12 0DP, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Classification
Categories:
A61K 9/00, A61K 31/138, A61K 31/58, A61K 45/06, A61P 11/08
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 16.1.2020
Expires: 25.2.2021
Payer: Örn Þór
Number: 13
Paid: 13.1.2021
Expires: 25.2.2022
Payer: Örn Þór slf.
Number: 14
Paid: 19.1.2022
Expires: 25.2.2023
Payer: Patice ehf.
Number: 15
Paid: 19.1.2023
Expires: 25.2.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 29.1.2024
Expires: 25.2.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 29.1.2025
Expires: 25.2.2026
Payer: Árnason Faktor ehf.
Number: 18
Paid: 16.2.2026
Expires: 25.2.2027
Payer: Árnason Faktor ehf.